by awkolaw2 | May 6, 2018 | Defective Drugs
FDA was worried Nuplazid was risky but approved its use anyway Nuplazid (pimavanserin) is an anti-psychotic drug manufactured by Acadia Pharmaceuticals that is approved for use in the treatment of debilitating and frightening psychosis in Parkinson’s patients. The...